VYOME HOLDINGS, INC. Accrued Income Taxes, Current
VYOME HOLDINGS, INC. (HIND) had Accrued Income Taxes, Current of $211.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2025-05-20
- 2025-03-31: Accrued Income Taxes, Current $211.00K.
- 2024-12-31: Accrued Income Taxes, Current $30.00K.
- 2024-09-30: Accrued Income Taxes, Current $44.00K.
- 2024-06-30: Accrued Income Taxes, Current $58.00K.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2025-03-31 | $211.00K 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $30.00K 10-Q · filed 2025-05-20 | |
| 2024-09-30 | $44.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $58.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $52.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $61.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $54.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $68.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $122.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $119.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $120.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $190.00K 10-Q · filed 2022-08-19 | |
| 2022-03-31 | $396.00K 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $326.00K 10-K · filed 2023-04-17 | $307.00K 10-K · filed 2022-04-08 |
| 2021-09-30 | $388.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $455.00K 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $265.00K 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |